ISSN: 2538-2462
October 2022
Vol. 7 No. 4 (2022)
Insulin Neuroprotection: Would We Experience the Second Insulin-Related Turning Point?
Journal of Cellular & Molecular Anesthesia,
Vol. 7 No. 4 (2022),
,
Page 195-196
https://doi.org/10.22037/jcma.v7i4.39388
Abstract
- Insulin
- Neuroprotection
- Regenerative Medicine
How to Cite
References
Vecchio I, Tornali C, Bragazzi NL, Martini M. The Discovery of Insulin: An Important Milestone in the History of Medicine. Front Endocrinol (Lausanne). 2018;9:613.
Tabashi S, Tajbakhsh A, Dahi M, Dabir S, Vosoughian M, Moshari M. Regenerative Medicine And Perioperative Hypoxic Organ Damage: Targeting Hypoxia-Inducible Factors. J Cell Mol Anesth. 2021;7(1):58-65.
Tajbakhsh A, Tabashi S. Apoptosis, Autophagy, and Anesthesia; Correlation of the Three “A”s. J Cell Mol Anesth. 2021;6(1):1-2.
Dabbagh A. Regenerative Medicine: Fact or Myth? J Cell Mol Anesth. 2022;7(1):1.
Buchheit T, Huh Y, Maixner W, Cheng J, Ji RR. Neuroimmune modulation of pain and regenerative pain medicine. J Clin Invest. 2020;130(5):2164-76.
Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, et al. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. Stem Cell Res Ther. 2022;13(1):366.
Tofighi Zavareh MA, Kargar Godaneh MH, Eslahi P, Aliaghaei A, Asghari MAA, Z., Payvandi AA, et al. Insulin Can Improve the Normal Function of the Brain by Preventing the Loss of the Neurons. J Cell Mol Anesth. 2022;7(4):197-202.
Zali H, Golchin A, Farahani M, Yazdani M, Ranjbar MM, Dabbagh A. FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy. Iran J Pharm Res. 2019;18(3):1639-47.
- Abstract Viewed: 68 times
- PDF Downloaded: 43 times
